Bruker (BRKR) Other Non-Current Assets (2010 - 2026)
Bruker (BRKR) reported Other Non-Current Assets of $832.2 million for Q1 2026, up 19.23% on a YoY basis from $698.0 million in Q1 2025, and down 0.55% quarter-over-quarter from $836.8 million in Q4 2025.
Bruker (BRKR) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Bruker has reported Other Non-Current Assets for 17 years, with the latest figure at $832.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 19.23% year-over-year to $832.2 million; the trailing twelve-month figure through Mar 2026 stood at $832.2 million (up 19.23% YoY), and the FY2025 full-year result was $836.8 million, up 259.6% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $832.2 million, down from $836.8 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $868.8 million in Q3 2025, with the low at $15.6 million in Q4 2023.
- Historically, Other Non-Current Assets has averaged $405.5 million across 5 years, with a median of $284.3 million in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 89.94% — and 2024, when it soared 1391.67%.
- Bruker's Other Non-Current Assets stood at $155.1 million in 2022, then slumped by 89.94% to $15.6 million in 2023, then soared by 1391.67% to $232.7 million in 2024, then jumped by 259.6% to $836.8 million in 2025, then decreased by 0.55% to $832.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $832.2 million (Q1 2026), $836.8 million (Q4 2025), and $868.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Bruker | 8.73 Bn | 8.60 Bn | 379.80 Mn | 832.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 832.20 Mn |
| Dec 31, 2025 | 836.80 Mn |
| Sep 30, 2025 | 868.80 Mn |
| Jun 30, 2025 | 799.80 Mn |
| Mar 31, 2025 | 698.00 Mn |
| Dec 31, 2024 | 232.70 Mn |
| Sep 30, 2024 | 238.10 Mn |
| Jun 30, 2024 | 185.50 Mn |
| Mar 31, 2024 | 193.60 Mn |
| Dec 31, 2023 | 15.60 Mn |
| Sep 30, 2023 | 410.20 Mn |
| Jun 30, 2023 | 292.70 Mn |
| Mar 31, 2023 | 294.20 Mn |
| Dec 31, 2022 | 155.10 Mn |
| Sep 30, 2022 | 283.30 Mn |
| Jun 30, 2022 | 272.60 Mn |
| Mar 31, 2022 | 284.30 Mn |
| Dec 31, 2021 | 70.80 Mn |
| Sep 30, 2021 | 206.70 Mn |
| Jun 30, 2021 | 200.00 Mn |